Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0AC0A
|
||||
Former ID |
DIB000605
|
||||
Drug Name |
SB-612111
|
||||
Synonyms |
N/OFQ receptor antagonist (inflammatory disease), SRI International
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Inflammatory disease [ICD9: 140-229, 147, 173, 573.3, 710-719; ICD10:C11, C44, K75.9, M00-M25] | Investigative | [539048] | ||
Company |
SRI International
|
||||
Structure |
Download2D MOL |
||||
Formula |
C24H29Cl2NO
|
||||
InChI |
InChI=1S/C24H29Cl2NO/c1-16-4-2-5-20-19(16)9-8-17(14-23(20)28)15-27-12-10-18(11-13-27)24-21(25)6-3-7-22(24)26/h2-7,17-18,23,28H,8-15H2,1H3/t17-,23-/m0/s1
|
||||
InChIKey |
OHRDCQFCAWLDBP-SBUREZEXSA-N
|
||||
CAS Number |
CAS 371980-98-2
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nociceptin receptor | Target Info | Antagonist | [543766] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.